Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Clin Pharmacol. 2017 Jun 1;57(10):1295–1304. doi: 10.1002/jcph.936

Table 8.

Predicted, observed and predicted/observed ratios for AUC, Cmax and Ctrough: Comparison of changes in LPV exposure with CYP inhibitors or inducers

CYP modulator CYP
modulator
regimen
[mg]
LPV/RTV
regimen [mg]
Pred
AUC
ratio
Obs
AUC
ratio
Ratio
pred/obs,
AUC
Pred
Cmax
ratio
Obs
Cmax
ratio
Ratio
pred/obs,
Cmax
Pred
Ctrough
ratio
Obs
Ctrough
ratio
Ratio pred/obs,
Ctrough
Omeprazole 40 QD 400/100 BID 1.04 1.07 0.98 1.03 1.08 0.96 1.06 1.03 1.03

Ketoconazole 200 SD 400/100 BID 1.52 0.87 1.74 1.52 0.89 1.70 1.45 0.75 1.94

400/100 BID 0.66 0.25 2.65 0.64 0.45 1.42 0.59 0.01 59.0
Rifampin 600 QD 400/400 BID 1.02 0.98 1.04 1.01 0.93 1.09 1.02 1.03 0.99
800/200 BID 0.91 0.84 1.08 0.90 1.02 0.88 0.92 0.43 2.14

RTV 100 BID 400/100 BID 1.47 1.46 1.01 1.39 1.28 1.09 1.59 2.16 0.74

Abbreviations: AUC= area under the plasma concentration-time curve, BID= twice daily, Cmax= maximum plasma concentration, Ctrough= trough plasma concentration, CYP= cytochrome P450, LPV= lopinavir, obs=observed, mg=milligram, pred=predicted, QD=once daily, SD=single dose, RTV=ritonavir

Predicted ratios were derived from arithmetic means; the type of means for the observed ratios is not specified in the lopinavir/ritonavir U.S. prescribing information.